Molecular and clinical diversity in primary central nervous system lymphoma

Autor: Hernández-Verdin, I., Kirasic, E., Wienand, K., Mokhtari, K., Eimer, S., Loiseau, H., Rousseau, A., Paillassa, J., Ahle, G., Lerintiu, F., Uro-Coste, E., Oberic, L., Figarella-Branger, D., Chinot, O., Gauchotte, G., Taillandier, L., Marolleau, J.-P., Polivka, M., Adam, C., Ursu, R., Schmitt, A., Barillot, N., Nichelli, L., Lozano-Sánchez, F., Ibañez-Juliá, M.-J., Peyre, M., Mathon, B., Abada, Y., Charlotte, F., Davi, F., Stewart, C., de Reyniès, A., Choquet, S., Soussain, C., Houillier, C., Chapuy, B., Hoang-Xuan, K., Alentorn, A.

Publikováno v: Annals of Oncology
Annals of Oncology, 2023, 34 (2), pp.186-199. ⟨10.1016/j.annonc.2022.11.002⟩
Annals of Oncology, 2022, ⟨10.1016/j.annonc.2022.11.002⟩

Primary central nervous system lymphoma (PCNSL) is a rare and distinct entity within diffuse large B-cell lymphoma presenting with variable response rates probably to underlying molecular heterogeneity.To identify and characterize PCNSL heterogeneity

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2154751d44b0ce2dfb8166b59184dd1b
https://doi.org/10.1016/j.annonc.2022.11.002